Dr. Kasturi Etukuru, MD

Dr. Etukuru practices at Southern Ocean Medical Center in Manahawkin, New Jersey, part of Hackensack Meridian Health.

Dr. Etukuru's NPI, 1912117300, was assigned on May 23, 2007. Dr. Etukuru holds New Jersey license 25MA08605300.

Dr. Etukuru's primary practice is Southern Ocean Medical Center, at 1140 Rt 72 W, Manahawkin, NJ 08050 in Ocean County. The practice phone is (609) 597-6011. Dr. Etukuru also practices at Southern Ocean Medical Center, 1301 State Highway 72, Manahawkin, NJ 08050.

Dr. Etukuru's primary practice is Southern Ocean Medical Center in Manahawkin, New Jersey, part of Hackensack Meridian Health. Dr. Etukuru is also affiliated with Jersey Shore University Medical Center. The medical group on file is RWJBarnabas Health Medical Group. Dmand AI also links Dr. Etukuru to 4 more hospitals, 2 medical groups, 1 physician office, 1 hospice and 1 skilled nursing facility, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Etukuru practices, 9 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Etukuru's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Etukuru's licenses on file in 2 states: New Jersey and New York.

CMS data shows 2,977 Medicare services from Dr. Etukuru across 9 procedure codes in 2024, for 932 Medicare patients. Medicare paid $273,149 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 932 Medicare patients who saw Dr. Etukuru in 2024. The largest group is 75 to 84, with 367 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 2.25, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Etukuru's median patient age at 78, with 50% women.

In 2024, Dr. Etukuru wrote 1,262 Medicare Part D claims for 445 patients. 89% of them were for generic drugs. CMS names the drug for 836 of them, across 30 drugs with 11 or more claims each, at $22,605 in total drug cost. In 2023, CMS named 616 claims across 28 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 39 out of 100 for Dr. Etukuru for performance year 2024, reported individually. Dr. Etukuru accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 65 general payments to Dr. Etukuru from 10 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $586.